Intrinsic Value of S&P & Nasdaq Contact Us

Solventum Corporation SOLV NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
73/100
6/7 Pass
SharesGrow Intrinsic Value
$6.98
-89.9%
Analyst Price Target
$100.50
+45.6%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Solventum Corporation (SOLV) has shown moderate revenue growth over the past 3 years, expanding from $8.1B to $8.3B (average +0.8%/yr). Net income reached $1.6B, reflecting exceptional earnings expansion at +53.6%/yr on average. The net profit margin is 18.7%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 53.5% (high), with a -4.2pp trend over the period. With a $12B market cap and MOAT composite score of 71/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 6-year history, the company was profitable in 6 of 6 years — a perfect long-term track record
  • INCOME (70/100, Pass) — proves strong profitability and pricing power
  • MOAT (71/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 73/100 with 6/7 criteria passed.

73/100
SG Score
View full scorecard →
VALUE
76/100
Price-to-Earnings & upside
→ IV page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $8.88
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
71/100
Score: 71/100
GM 53.5% (-4.2pp)
Proven by this page
GROWTH
73/100
Rev +0.8%/yr
NI +53.6%/yr
Proven by this page
INCOME
70/100
Margin 18.7%
$8.3B
Proven by this page
Solventum Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $8.33B$8.33B$8.25B$8.2B$8.13B
Gross Profit $4.45B$4.45B$4.59B$4.69B$4.7B
Gross Margin 53.5%53.5%55.6%57.3%57.7%
Operating Income $2.18B$2.18B$1.04B$1.69B$1.69B
Net Income $1.56B$1.56B$479M$1.35B$1.34B
Net Margin 18.7%18.7%5.8%16.4%16.5%
EPS (Diluted) $8.88$8.88$2.76$7.79$7.79
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message